26 June 2025
GenIP Plc
("GenIP" or the "Company")
Result of AGM
GenIP Plc (AIM: GNIP), a technology business providing Generative Artificial Intelligence (GenAI) solutions to help research organisations and corporations commercialise their innovations, is pleased to announce that at the Company's Annual General Meeting ("AGM") held earlier today all resolutions were duly passed.
The number of votes cast for and against each of the resolutions proposed, and the number of votes withheld were as follows:
| Resolution | For | % | Against | % | Votes withheld | Total votes cast |
| Ordinary Resolutions | ||||||
| (1) Approval of the Annual Report and Accounts | 13,895,578 | 99.95 | 6,685 | 0.05 | 104,665 | 13,902,263 |
| (2) Re-appoint HW Fisher LLP as auditor of the Company | 13,895,578 | 99.95 | 6,685 | 0.05 | 104,665 | 13,902,263 |
| (3) Authorise the Directors to determine the auditor's remuneration | 13,895,578 | 99.95 | 6,685 | 0.05 | 104,665 | 13,902,263 |
| (4) Re-elect Lord David Willetts as a director of the Company | 13,767,373 | 99.03 | 134,890 | 0.97 | 104,665 | 13,902,263 |
| (5) Re-elect Melissa Cruz as a director of the Company | 13,767,373 | 99.03 | 134,890 | 0.97 | 104,665 | 13,902,263 |
| (6) Re-elect Kevin Fitzpatrick as a director of the Company | 13,895,578 | 99.95 | 6,685 | 0.05 | 104,665 | 13,902,263 |
| (7) Re-elect Prof. David Gann CBE as a director of the Company | 13,767,373 | 99.03 | 134,890 | 0.97 | 104,665 | 13,902,263 |
| (8) To authorise the Directors to allot shares, up to an aggregate nominal amount of £37,224.61 | 13,759,681 | 99.03 | 134,890 | 0.97 | 112,357 | 13,894,571 |
| Special Resolution | ||||||
| (9) To authorise the Directors to disapply pre-emption rights when issuing share, up to an aggregate nominal amount of £37,224.61 | 13,759,681 | 99.03 | 134,890 | 0.97 | 112,357 | 13,894,571 |
Notes:
1. Proxy appointments which gave discretion to the Chairman of the AGM have been included in the "For" total for the appropriate resolution.
2. Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution.
3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against".
4. The full text of the resolutions passed at the AGM can be found in the Notice of Annual General Meeting which is available on the Company's website at http://genip.ai/results-presentations/.
As at 26 June 2025, there were 17,517,461 ordinary shares in issue. Shareholders are entitled to one vote per share.
Votes withheld are not votes in law and so have not been included in the calculation of the proportion of votes for and against a resolution.
Enquiries:
| GenIP Plc Melissa Cruz, CEO | | Via Redchurch Communications |
| | | |
| Beaumont Cornish Limited (Nominated Adviser) Roland Cornish / Asia Szusciak / Andrew Price
| | Tel: +44 (0) 20 7628 3396
|
| Novum Securities Limited (Broker) Jon Belliss |
| Tel: +44 (0)20 7399 9425 JBelliss@novumsecurities.com
|
| Redchurch Communications (Financial PR) John Casey
| |
|
Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.
About GenIP
GenIP provides generative artificial intelligence (GenAI) analytic services to help companies, research institutions and venture funds assess and commercialise new discoveries. GenIP combines expert human technical review with GenAI algorithms to provide insightful and verified services.
GenIP provides two complementary platform-based services:
1. Invention Evaluator: Provides bespoke research reports that assess the market potential of new technological innovations and discoveries using AI-driven proprietary software; and
2. Vortechs: which is an executive recruitment platform that through advanced machine learning algorithms and natural language processing technologies assists in matching technology organisations with experienced executives skilled in technology commercialisation.
The Company believes that its integrated GenAI service offerings will help organisations to evaluate and commercialise their technological innovations.
Company Strategy
GenIP's goal is to be a leading Generative AI analytic services company. To achieve this, the Company has established three strategic pillars:
· Organically grow Invention Evaluator and Vortechs' revenue through institutional and corporate connections as well as increase client pipeline through marketing, advertising and social media spend.
· Expand the Generative AI service offerings within Invention Evaluator and Vortechs' to reach new customers and improve margins.
· Bolt-on acquisitions of additional Generative AI services that are helpful to our clients and have demonstrated initial market traction.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.